Chronic GvHD is the leading cause of non-relapse mortality in recipients of hematopoietic cell transplantation. Although the benefit of physical therapy (PT) has been reported in some GvHD studies, a literature gap is identified in demonstrating the exact role of different types of PT interventions and their impact on GvHD outcomes. An electronic search was undertaken using 13 peerreviewed databases from 1994 to 2016. JADAD scoring method was used to score the quality of articles. PT interventions utilized for non-GvHD aspects of transplantation were excluded. Out of the 4775 articles on the electronic search, 297 articles were reviewed out of which 3 fulfilled the selection criteria. Moderately high evidence for effectiveness of supervised PT intervention was found, whereas moderate evidence for a self-administered exercise program was established. No safety concerns with PT were observed in any of the studies, however none of the studies were conducted to directly evaluate safety and effectiveness specifically in GvHD patients. PT is a safe but understudied therapy for GvHD. Limited evidence on the effectiveness of most PT interventions is available through randomized control trials. Well-designed trials are urgently needed for musculoskeletal GvHD especially with focused PT interventions.
INTRODUCTION
Hematopoietic cell transplant (HCT) is the only potentially curative therapy for many malignant and non-malignant conditions and its utilization is increasing as a result of reduced morbidity and an increased life expectancy. 1 Unfortunately, the success of the HCT is hindered by chronic cGvHD, which is the leading cause of nonrelapse mortality. 2, 3 cGvHD also leads to significant impairment and reduced quality of life (QoL) due to wide spread impact on the physical and psychologic functioning of the patient. 4, 5 Currently 430 000 allogeneic HCTs are being performed annually worldwide, and due to increased use of G-CSF mobilized peripheral blood cells, advanced age of HCT recipients, and an increased utilization of unrelated donors, the overall burden of cGvHD has increased tremendously. [6] [7] [8] cGvHD can affect several organs or sites in the body including the musculoskeletal system, but among the many challenges faced, development of fasciitis, scleroderma or fibrosis affecting the skin and joints is one of the main concerns for the physical therapists. 9 Polymyositis has also been identified as one of the rare autoimmune manifestations of cGvHD. 10 Like all chronic diseases, cGvHD management paradigm has two approaches-pharmacologic (both systemic and topical), and ancillary/supportive care. Despite a six decade history of allogeneic HCT, the pharmacological interventions used for the prevention of GvHD have limited utility; 11 additionally, the clinical trials of pharmacologic therapies have failed to produce sustained anti-GvHD effects. Therefore, no drugs have been approved for cGvHD treatment by any country's regulatory authorities. When it comes to supportive care, the National Institutes of Health Consensus cGvHD Ancillary Therapy and Supportive Care Working Group Report has specific recommendations for the musculoskeletal system GvHD. 12 Referral to physical therapy (PT) is grade AIII recommendation of the 2014 NIH cGvHD expert panel, yet in clinical practice, we don't see routine incorporation of PT services into GvHD management. Managing the musculoskeletal impact of cGvHD on patients via PT has been by far limited to exercise therapy and the possibilities of other PT expertise, that is, manual treatment for techniques or modalities and their potential benefits on some aspects on the cGvHD is lacking in the literature. So, the purpose of this review is to systematically summarize and analyze the impact of PT intervention as a whole rather than just exercises in managing cGvHD post allogenic HCT; additionally we also assessed the role of PT on the QoL, physical function and the psychological wellbeing in the HCT survivors.
articles (Table 2 ). All papers were independently reviewed. Discrepancies in data extraction were resolved through discussion. JADAD scoring method was used to score the articles as per Table 3 . 13 The Jadad score is one of the tools used to assess the methodological quality of controlled trials. Randomization, masking and accountability of all patients, including withdrawals are the three main methodological features against which the studies are scored. There are five questions which are answered as 'yes' or 'no'. Each 'yes' gives one point and each 'no' takes away a point (subtracted).
RESULTS
Out of 4775, only 244 articles were found to be in English (Figure 1 ). Further 53 articles were identified via manual search. After the precluding the duplicates, 251 articles were screened, out of which 246 were excluded. Full-text articles were obtained for the remaining six articles; one study was further excluded as it was a case study. None of the studies were conducted to directly evaluate safety and effectiveness specifically in GvHD patients.
Out of the five studies that were finalized, the Finnish study was a long-term evaluation of physical performance in pediatric patients after allogeneic HCT. 14 The results of this study confirm lower physical performance in patients with chronic GvHD and only indirectly suggest that these patients may benefit from an exercise program, due to the observation that children who are sports club members have better physical functioning. The Wiskemann et al. 15 study ('PETRA' trial) was also among the five articles, which were initially chosen that evaluated the effect of early exercise on long-term outcomes of allogeneic HCT, including chronic GvHD. However, this paper was just a description of a study protocol. This study is not yet conducted and so this article was also excluded from the final set of studies.
The Baumann et al. 16 study was described as a randomized controlled pilot study performed at the center for transplantation in Germany. About 64 inpatients were randomly assigned to either a training group (32) or a control group (32) . Both qualitative and quantitative measurements were used in this study to monitor the progress between the groups and are described in the Table 4 . The intervention group started their exercise training about 6 days before the transplant twice a day. Their training included a combination of aerobic endurance training on a bicycle ergometer and an 'ADL-training'. During chemotherapy and after engraftment the patients took part in a daily 20 min exercise program of walking, stepping and stretching. Patients in the control group received a so-called passive and active mobilization with a low intensity.
During the hospitalization, the intervention group showed no change in their endurance performance (88.3 versus 86.5 W, difference 2%), however, there was a significant decrease in the endurance performance in the control group (82.0 versus 60.0 W, difference 27%).
In conclusion, no statistically significant differences were found between the control and the intervention groups regarding the various parameters namely modified endurance test according to the World Health Organization scheme, strength performance of the extensor muscles of the thighs and the lung function.
The study by Wiskemann et al. 17 was a prospective, multicenter, clinical randomized control trial and compared a self-administered exercise intervention with a social contact control group. From the sample size of 105 patients, 80 patients (40 per group) completed the study. The authors described the intervention (Table 4) in detail, with the exercise group starting exercise (outpatient) 1-4 weeks before admission. After randomization, an exercise specialist was also involved who gave one practical introduction session followed by a training manual, which included an exercise DVD. Three different strength-training protocols were used: (1) focused on extremities, (2) the entire body or (3) bed exercises (limited to inpatient period). Patients in the control group were instructed on moderate physical activity and no further advice was provided. During in patient stay, the control group was granted access to the stationary cycles and treadmills same as the intervention group. PT was also offered for up to three times per week with an average session of 30 min. Comparing pre-post group mean differences, significant improvements were shown for the exercise group in POMS subscale 'Anger/Hostility' (P = 0.02; interaction effect P = 0.03) and EORTC subscale 'pain' (P = 0.007; interaction effect, P = 0.04). The intervention group also performed well on the 6-min walk test (P = 0.02) and comparing pre-post mean differences (P = 0.006). The lower limb strength also was shown to have improved (P = 0.03) however, no significant improvement was seen in the pedometer steps and coordination tasks. The overall result for the intervention group was reported as significant improvements in strength, endurance and general fatigue. Interestingly only the Wiskemann et al. 17 study mentioned the organs that were involved namely skin, liver and gastrointestinal, however, the severity was not mentioned. None of the studies have mentioned the joints that were affected or the severity of the joint or muscle problems and none of the studies have used the Rodnan Skin Score.
Jarden et al. 18 study was a prospective, two-armed randomized controlled trial that, by four time points (baseline, post, 3-and 6-month follow-up), compared an intervention group with a control group. Total 34 of 42 patients completed all study requirements at post-testing. Patients in the intervention group received both usual care and the multimodal intervention based on exercise recommendations for cancer patients and survivors combined with progressive relaxation and psychoeducation. Patients in the control group received usual care including the departments' standard of care of physical activity. Physiotherapy was offered, which included range of motion, resistance and massage, however the frequency, intensity and duration was patient dependent. Qualitative and quantitative measures used to monitor the progress and QoL in the patient are outlined in Table 4 . Records identified through database search in english, n = 244
Records identified through manual search, n = 53
Records after duplicates taken out, n = 251
Records screened, n = 251
Total records excluded, n = 246 Animal studies, n = 7 Did not meet inclusion criteria , n = 236
Couldn't find full text article, n = 1 Reviews, n = 2
Full text articles assessed for eligibility, n = 6
Total full text articles excluded, n = 1 Case reports, n = 1 PETRA study, n = 1
Included studies, n = 3 Physical therapy in GvHD J Mohammed et al Table 4 . Physical therapy in GvHD J Mohammed et al
Significant difference was reported in favor of the intervention group at post-testing for VO 2 max (P o 0.0001), muscle strength for the chest press (P o0.0001), leg extension (P = 0.0003), isometric right elbow flexors (P = 0.0009), isometric right knee extensors (P o 0.0001) and the stair test (P = 0.0008). No statistically significant difference was reported between groups on psychological well-being (HADS), EORTC-QLQ-C30 or Functional Assessment of Cancer Therapy scale.
In conclusion, this study showed a strong correlation between PT intervention and aerobic fitness, muscle strength. The patients in the intervention group had minimal loss of functional performance and reduced intensity of diarrhea. Furthermore, exercise intervention seems to suggest that there is a positive influence of the intervention on QoL, fatigue and psychological well-being up to 6 months after allo-HSCT.
DISCUSSION
Steroid refractory chronic GvHD is an incurable disease for most of the patients suffering from it, and results in loss of function and independence, thereby significantly reducing the QoL. Physical rehabilitation, even in advanced cGvHD, can help in maintaining or restoring musculoskeletal system function, which would allow patients to retain some mobility and independence. This important aspect of supportive care can contribute to a reduced burden on families and caregivers, and a better QoL. Since HCT is usually performed in tertiary-care centers, it is expected that those centers would have well-established PT departments. Only a handful of the transplant centers in the world have formal GvHD clinics, which may be regularly collaborating with the PT departments; the actual need to involve rehabilitation services early in the course of GvHD may be much higher. Currently, billions of US dollars are being invested in novel agent development for GvHD, yet, our search indicates that no randomized trial has been undertaken evaluating the efficacy of the low-cost strategy of PT specifically for GvHD. PT as a profession has a lot to offer patients suffering from cGvHD. Exercise, although important, is just one of the many interventions to improve the QoL of a patient. Most of the PT modalities are non-invasive, inexpensive, do not involve any drugs, are easy to administer, less time consuming, with relatively few contraindications and sometimes can be self-administered by the patients in their homes. These modalities/treatment techniques are evidence based and have already been proven to have a long-term benefit for the patient when it comes to pain relief, tissue healing and improving QoL.
Some of the most common treatment techniques used by the PTs, which can have a positive impact on the QoL of patients with cGvHD in treating pain, soft tissue problems such as fasciitis, fibrosis, myositis and so on include transcutaneous electrical nerve stimulation (TENS) for both acute and chronic pain management, [19] [20] [21] [22] [23] [24] therapeutic ultrasound, which can have a direct therapeutic effect on the periosteum, collagenous tissues and fibrotic muscle, [25] [26] [27] and influence all the tissue healing phases. For example, therapeutic ultrasound stimulates the mast cells, platelets, white cells with phagocytic roles and the macrophages. 28, 29 Extracorporeal shock wave therapy has proven benefits of enhancing angiogenesis and aids tissue healing; and finally Myofascial Release has also proven to help manage pain. 30 This type of technique has also shown to reduce inflammation. 31, 32 It is also worth mentioning that cGvHD patients can also benefit from further extended areas of PT, again which have not been explored and include role of PT in sexual health or treating pelvic pain 33 as a result of cGvHD; 34 finally the role of PT-led functional evaluation for patients returning to work has not been evaluated. 35, 36 Our search did identify three studies, which were done in the HCT arena that directly or indirectly measure effects on GvHD. Among those studies, although the Baumann et al. study 16 was a well-conducted randomized trial of exercise, it did not show any significant difference in outcomes, and the observed increase in acute GvHD in the exercise group was likely a coincidental finding.
The BMT CTN 0902 was a large randomized trial, which tested the efficacy of training patients to engage in self-directed exercise and stress management during their HCT. The results of this trial indicated no differences in the primary end points of the physical and mental component scales of the SF36 at day 100 among the groups based on an intention-to-treat analysis. There were no differences observed in overall survival, hospital days through day 100 post HCT or in other patient-reported outcomes, including treatment-related distress, sleep quality, pain and nausea. Notably, PT was not an intervention for treatment of acute or chronic GvHD in this trial; thus this study could not be included in our final selection of studies. PT is being put forward as an important ally in the management of cGvHD, and is considered a safe and effective way to improve patient's physical, physiological, psychological and psychosocial well-being. 37, 38 On the basis of the existing literature, it is evident that exercises have proven benefit on the QoL of patients in cGvHD and there is an argument that may be all hospitals should develop and provide PT services for patients undergoing allogeneic HCT. 39 
CONCLUSIONS
PT is a safe significantly but understudied therapy for GvHD. Limited evidence on the effectiveness of most PT interventions is available through randomized control trials. Our comprehensive review of literature identifies data on evaluation of exercise parameters in HCT survivors, however, randomized trials including dedicated PT management by physical therapists have not been reported in literature. It is a time to test non-invasive intervention to optimize QoL in patients undergoing HCT. Well-designed trials are urgently needed for musculoskeletal GvHD especially with focused PT interventions.
